Table 3.
IRR and 95% CI from multivariable models by ethnic group, for all cancers and by diagnostic group, 0–29 years, Yorkshire, 1998–2009
| Ethnic classification and group | All cancers | Leukaemia | Lymphoma | CNS tumours | ||||
| IRR | (95% CI) | IRR | (95% CI) | IRR | (95% CI) | IRR | (95% CI) | |
| HES | ||||||||
| White | 1 | – | 1 | – | 1 | – | 1 | – |
| South Asian | 0.90 | (0.79 to 1.02) | 0.85 | (0.64 to 1.13) | 1.04 | (0.79 to 1.38) | 0.73 | (0.53 to 1.01) |
| Other | 1.32 | (1.13 to 1.53) | 0.79 | (0.52 to 1.21) | 1.46 | (1.05 to 2.04) | 1.30 | (0.92 to 1.85) |
| Onomap | ||||||||
| White | 1 | – | 1 | – | 1 | – | 1 | – |
| South Asian | 0.89 | (0.79 to 1.00) | 0.84 | (0.64 to 1.12) | 1.18 | (0.92 to 1.50) | 0.65 | (0.47 to 0.91) |
| Other | 1.09 | (0.93 to 1.27) | 1.08 | (0.76 to 1.54) | 0.97 | (0.66 to 1.41) | 1.15 | (0.80 to 1.65) |
| CHP | ||||||||
| White | 1 | – | 1 | – | 1 | – | 1 | – |
| South Asian | 0.95 | (0.84 to 1.07) | 1.01 | (0.78 to 1.31) | 1.10 | (0.86 to 1.42) | 0.70 | (0.50 to 0.96) |
| Other | 1.41 | (1.23 to 1.62) | 0.98 | (0.68 to 1.43) | 1.50 | (1.10 to 2.04) | 1.43 | (1.03 to 1.98) |
| COP | ||||||||
| White | 1 | – | 1 | – | 1 | – | 1 | – |
| South Asian | 1.07 | (0.96 to 1.20) | 1.05 | (0.81 to 1.35) | 1.36 | (1.08 to 1.71) | 0.78 | (0.57 to 1.05) |
| Other | 0.78 | (0.65 to 0.94) | 0.67 | (0.43 to 1.05) | 0.72 | (0.47 to 1.12) | 0.93 | (0.62 to 1.38) |
Models adjusted for age group, sex and year.
CHP, ‘Combined HES priority’; CNS, central nervous system; COP, ‘Combined Onomap priority’; HES, Hospital Episode Statistics; IRR, incidence rate ratio.